Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1999 1
2001 3
2002 1
2003 3
2005 1
2006 2
2007 1
2008 1
2009 1
2010 1
2011 2
2012 1
2013 1
2014 3
2015 1
2016 1
2017 1
2018 1
2019 2
2020 4
2021 1
2022 3
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Total fertilization failure after ICSI: insights into pathophysiology, diagnosis, and management through artificial oocyte activation.
Campos G, Sciorio R, Esteves SC. Campos G, et al. Hum Reprod Update. 2023 Jul 5;29(4):369-394. doi: 10.1093/humupd/dmad007. Hum Reprod Update. 2023. PMID: 36977357 Review.
BACKGROUND: Total fertilization failure (TFF) is the failure of all metaphase II oocytes to fertilize in ART cycles. ...WIDER IMPLICATIONS: AOA treatments represent a promising therapy to overcome fertilization failure caused by sperm- and oocyte-relat …
BACKGROUND: Total fertilization failure (TFF) is the failure of all metaphase II oocytes to fertilize in ART cycles. ...WIDER …
The Therapeutic Potential of Human Umbilical Cord Derived Mesenchymal Stem Cells for the Treatment of Premature Ovarian Failure.
Umer A, Khan N, Greene DL, Habiba UE, Shamim S, Khayam AU. Umer A, et al. Stem Cell Rev Rep. 2023 Apr;19(3):651-666. doi: 10.1007/s12015-022-10493-y. Epub 2022 Dec 15. Stem Cell Rev Rep. 2023. PMID: 36520408 Free PMC article. Review.
Premature ovarian failure (POF) affects 1% of women under 40, leading to infertility. ...Therefore, an innovative treatment strategy like the regeneration of premature ovaries by using human umbilical cord mesenchymal stem cells (hUC-MSCs) can be a cho …
Premature ovarian failure (POF) affects 1% of women under 40, leading to infertility. ...Therefore, an innovative treat …
Impacts of endometrioma on ovarian aging from basic science to clinical management.
Tan Z, Gong X, Li Y, Hung SW, Huang J, Wang CC, Chung JPW. Tan Z, et al. Front Endocrinol (Lausanne). 2023 Jan 4;13:1073261. doi: 10.3389/fendo.2022.1073261. eCollection 2022. Front Endocrinol (Lausanne). 2023. PMID: 36686440 Free PMC article. Review.
Accumulated evidence has shown that pelvic and local microenvironments in women with OMA are manifested, causing detrimental effects on ovarian development and functions. Whilst clinical associations of OMA with poor ovarian reserve, premature ovarian …
Accumulated evidence has shown that pelvic and local microenvironments in women with OMA are manifested, causing detrimental effects on o …
Genetic dissection of spermatogenic arrest through exome analysis: clinical implications for the management of azoospermic men.
Krausz C, Riera-Escamilla A, Moreno-Mendoza D, Holleman K, Cioppi F, Algaba F, Pybus M, Friedrich C, Wyrwoll MJ, Casamonti E, Pietroforte S, Nagirnaja L, Lopes AM, Kliesch S, Pilatz A, Carrell DT, Conrad DF, Ars E, Ruiz-Castañé E, Aston KI, Baarends WM, Tüttelmann F. Krausz C, et al. Genet Med. 2020 Dec;22(12):1956-1966. doi: 10.1038/s41436-020-0907-1. Epub 2020 Aug 3. Genet Med. 2020. PMID: 32741963 Free PMC article.
Although the etiology of MA is likely to be of genetic origin, only 13 genes have been reported as recurrent potential causes of MA. ...Wider implications include the understanding of potential genetic links between nonobstructive azoospermia (NOA) and cancer predispositio …
Although the etiology of MA is likely to be of genetic origin, only 13 genes have been reported as recurrent potential causes of MA. …
Sexual and fertility adverse effects associated with chemotherapy treatment in women.
Turan V, Oktay K. Turan V, et al. Expert Opin Drug Saf. 2014 Jun;13(6):775-83. doi: 10.1517/14740338.2014.915940. Epub 2014 Apr 30. Expert Opin Drug Saf. 2014. PMID: 24784147 Review.
AREAS COVERED: This article reviews what is known about the effects of chemotherapy on fertility and sexuality. We also discuss risk factors for premature ovarian failure, fertility preservation options in patients willing to have a child after treatment, and …
AREAS COVERED: This article reviews what is known about the effects of chemotherapy on fertility and sexuality. We also discuss risk factors …
Investigation and treatment of premature ovarian insufficiency: A multi-disciplinary review of practice.
Richardson A, Haridass SA, Ward E, Ayres J, Baskind NE. Richardson A, et al. Post Reprod Health. 2018 Dec;24(4):155-162. doi: 10.1177/2053369118811233. Epub 2018 Nov 4. Post Reprod Health. 2018. PMID: 30392440
STUDY DESIGN: A retrospective review of all females diagnosed with premature ovarian insufficiency between 1 July 2016 and 30 June 2017, presenting to one of the following clinics: reproductive medicine, specialist menopause, general gynaecology, oncology lon …
STUDY DESIGN: A retrospective review of all females diagnosed with premature ovarian insufficiency between 1 July 2016 and 30 …
Antiresorptive therapy in the management of cancer treatment-induced bone loss.
Garg A, Leitzel K, Ali S, Lipton A. Garg A, et al. Curr Osteoporos Rep. 2015 Apr;13(2):73-7. doi: 10.1007/s11914-014-0252-x. Curr Osteoporos Rep. 2015. PMID: 25575469 Review.
Cytotoxic chemotherapies, radiation, and hormonal therapies can lead to premature menopause and decrease bone mineral density. Over 60 % of breast cancer patients within 1 year of beginning postoperative adjuvant chemotherapy experience ovarian fail …
Cytotoxic chemotherapies, radiation, and hormonal therapies can lead to premature menopause and decrease bone mineral d …
Fertility after breast cancer treatment.
Kasum M, Beketić-Orešković L, Peddi PF, Orešković S, Johnson RH. Kasum M, et al. Eur J Obstet Gynecol Reprod Biol. 2014 Feb;173:13-8. doi: 10.1016/j.ejogrb.2013.11.009. Epub 2013 Nov 17. Eur J Obstet Gynecol Reprod Biol. 2014. PMID: 24315568 Free article. Review.
The current choice for premenopausal women with breast cancer is adjuvant therapy which includes cytotoxic chemotherapy, ovarian ablation (by surgery, irradiation, or chemical ovarian suppression), anti-estrogen therapy, or any combination of these. .. …
The current choice for premenopausal women with breast cancer is adjuvant therapy which includes cytotoxic chemotherapy, ovarian …
Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the Childhood Cancer Survivor Study.
Green DM, Sklar CA, Boice JD Jr, Mulvihill JJ, Whitton JA, Stovall M, Yasui Y. Green DM, et al. J Clin Oncol. 2009 May 10;27(14):2374-81. doi: 10.1200/JCO.2008.21.1839. Epub 2009 Apr 13. J Clin Oncol. 2009. PMID: 19364956 Free PMC article. Review.
These studies were undertaken to determine the effect, if any, of treatment for cancer diagnosed during childhood or adolescence on ovarian function and reproductive outcomes. We reviewed the frequency of acute ovarian failure, premature menopause …
These studies were undertaken to determine the effect, if any, of treatment for cancer diagnosed during childhood or adolescence on ovari …
Management of the androgen-deficient woman.
Arlt W. Arlt W. Growth Horm IGF Res. 2003 Aug;13 Suppl A:S85-9. doi: 10.1016/s1096-6374(03)00060-1. Growth Horm IGF Res. 2003. PMID: 12914732 Review.
Significant androgen deficiency is present in adrenal and/or gonadal failure (e.g., due to Addison's disease, hypopituitarism, premature ovarian failure, or chronic glucocorticoid therapy). ...Androgen levels do not necessarily change during phy …
Significant androgen deficiency is present in adrenal and/or gonadal failure (e.g., due to Addison's disease, hypopituitarism, pre …
36 results